W A Gattis
Affiliation: Duke University Medical Center
- Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) StudyW A Gattis
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
Arch Intern Med 159:1939-45. 1999..The multidisciplinary approach to managing heart failure has been shown to improve outcomes. The role of a clinical pharmacist in treating heart failure has not been evaluated...
- Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)C M O'Connor
Duke University Medical Center, Durham, NC 27710, USA
Am Heart J 138:78-86. 1999..To evaluate clinical characteristics and outcomes of patients with advanced heart failure receiving intravenous continuous dobutamine in the FIRST Trial (Flolan International Randomized Survival Trial)...
- Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic functionC M O'Connor
Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina, USA
Am J Cardiol 86:863-7. 2000..Furthermore, several clinical and angiographic characteristics are predictive of long-term survival...
- The benefit of implementing a heart failure disease management programD J Whellan
Division of Cardiology, Department of Medicine, Box 3356, Duke University Medical Center, Durham, NC 27710, USA
Arch Intern Med 161:2223-8. 2001..We undertook this study to evaluate the potential benefit of implementing a CHF disease management program at a tertiary care center, particularly in terms of beta-blocker use and cost to the health care system...
- Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS)C M O'Connor
Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27710, USA
Am J Cardiol 88:541-6. 2001..The results of this secondary analysis suggest that aspirin 160 mg is more effective than aspirin 80 mg + warfarin 1 mg in preventing ischemic stroke in post-myocardial infarction patients...